Meeting
2022 ASCO Gastrointestinal Cancers Symposium
A natural history of gastroenteropancreatic neuroendocrine tumors evaluated at a tertiary cancer center: An observational study of 2,067 cases.
Authors
Benjamin Daniel Powers
Temple Univ Hosp, Philadelphia, PA
Benjamin Daniel Powers , Yaser Ahmad , Gabriel Diaz , Ozlem Tarhan , Taymeyah E. Al-Toubah , Mintallah Haider , Jason B. Fleming , Jonathan R. Strosberg , Daniel A. Anaya
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
DOI
10.1200/JCO.2022.40.4_suppl.508
Abstract #
508
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
First Author: Estephany Abou Jokh Casas
Poster
2019 Gastrointestinal Cancers Symposium
Resection of primary tumor in liver only metastatic midgut neuroendocrine tumors.
First Author: Nicholas Manguso
Poster
2015 ASCO Annual Meeting
Natural history and outcome in a large series of primary dermatofibrosarcoma protuberans (DFSP) treated at a reference institution.
First Author: Andrea Pierluigi Fontana
Poster
2014 ASCO Annual Meeting
Defining the neuroendocrine tumors landscape: A 15-year population-based analysis of incidence, outcomes, and therapies.
First Author: Julie I. Hallet